颅面骨纤维异常增殖症:肿瘤体积变化与血清降钙素及碱性磷酸酶关系的回顾性研究
术前降钙素与肿瘤存在相关(P=0.0442),ALP无相关(P=0.1125);长期随访中ALP与肿瘤复发显著相关(P=0.0096),降钙素无相关(P=0.4760),但ALP不反映肿瘤体积变化。
要点
- 术前血清降钙素与肿瘤存在相关,ALP与肿瘤存在无相关。
- 长期随访中血清ALP与肿瘤复发显著相关,降钙素与复发无相关。
- 血清ALP不反映肿瘤体积变化,随访需三维CT测量肿瘤体积。
核心结论
- 血清ALP可作为孤立性颅面骨纤维异常增殖症随访的实验室检查,但不能代表肿瘤体积变化。
- 随访中检测显著体积变化必须行三维CT扫描并测量肿瘤体积。
- 术前降钙素与肿瘤存在相关,建议扩大规模研究术前降钙素。
研究设计与样本
- 术前、术后即刻及长期随访时行三维CT扫描并肿瘤分割测量体积。
- 同一时间点检测血清ALP与降钙素水平,评估其与肿瘤体积的相关性。
主要发现
- 术前降钙素水平与肿瘤存在相关(P=0.0442),ALP与肿瘤存在无相关(P=0.1125)。
- 术前及术后期间肿瘤体积与ALP或降钙素水平均无显著关联。
- 长期随访中血清ALP与肿瘤复发显著相关(P=0.0096),血清降钙素与复发无相关(P=0.4760)。
- 血清ALP水平未反映肿瘤体积变化。
临床怎么用
- 对孤立性颅面骨纤维异常增殖症患者随访时可检测血清ALP作为实验室指标。
- 不能以血清ALP替代影像学评估肿瘤体积变化。
- 随访中需行三维CT扫描并测量肿瘤体积以发现显著体积变化。
- 可考虑术前检测血清降钙素,但其与肿瘤存在的关联需扩大规模研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The purpose of this study was to determine the usefulness of serum alkaline phosphatase (ALP) and calcitonin in the follow-up of tumor volume changes in patients with craniofacial fibrous dysplasia. METHODS: Twenty patients with isolated craniofacial fibrous dysplasia were included, who met our criteria for long-term follow-up. Three-dimensional computed tomography scans were obtained, and tumor segmentation was performed. The tumor volume was measured preoperatively, immediate postoperative and during long-term follow-up. Serum ALP and calcitonin levels were obtained at the same times to assess their correlation with tumor volumes. RESULTS: Preoperative calcitonin levels were correlated with the presence of tumor (P = 0.0442), whereas ALP levels were not (P = 0.1125). There were no significant associations between tumor volume and ALP or calcitonin levels in the preoperative or postoperative periods. During long-term follow-up, serum ALP was significantly associated with tumor recurrence (P = 0.0096), but serum calcitonin was not (P = 0.4760). However, serum levels of ALP did not reflect the tumor volume changes. CONCLUSIONS: Serum ALP may be useful as a laboratory test for follow-up of patients with isolated craniofacial fibrous dysplasia. However, it cannot represent the tumor's volume changes and 3-dimensional computed tomography scans with tumor volume measurement are mandatory for detecting significant volume changes during follow-up. Investigation of the serum calcitonin in the preoperative period is also recommended on a large scale because it was related to the presence of the tumor.
引用
- Hussein MA, Yun IS, Kim BO, et al. Craniofacial Fibrous Dysplasia: Retrospective Study on the Relationship Between the Tumor Volume Changes and the Circulating Serum Calcitonin and Serum Alkaline Phosphatase. Ann Plast Surg. 2017. PMID: 27922893. doi:10.1097/SAP.0000000000000917
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。